Poniard Pharmaceuticals (Poniard Pharmaceuticals) Enterprise Value : $0.00 Mil (As of Apr. 29, 2024)

Poniard Pharmaceuticals Enterprise Value Chart

Poniard Pharmaceuticals Annual Data
	Trend	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10
Enterprise Value		Get a 7-Day Free Trial					74.22	71.16	19.56	53.89	22.49

Poniard Pharmaceuticals Quarterly Data
	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11
Enterprise Value	Get a 7-Day Free Trial															19.16	22.49	20.90	11.70	7.15

Competitive Comparison of Poniard Pharmaceuticals's Enterprise Value

For the Biotechnology subindustry, Poniard Pharmaceuticals's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poniard Pharmaceuticals's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poniard Pharmaceuticals's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Poniard Pharmaceuticals's Enterprise Value falls into.

Poniard Pharmaceuticals Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Poniard Pharmaceuticals's Enterprise Value for the fiscal year that ended in Dec. 2010 is calculated as

Poniard Pharmaceuticals's Enterprise Value for the quarter that ended in Sep. 2011 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals  (OTCPK:PARD) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Poniard Pharmaceuticals's EV-to-EBIT for today is

Poniard Pharmaceuticals's current Enterprise Value is $0.00 Mil.
Poniard Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Sep. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15.53 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Poniard Pharmaceuticals's EV-to-EBITDA for today is:

Poniard Pharmaceuticals's current Enterprise Value is $0.00 Mil.
Poniard Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Sep. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.26 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Poniard Pharmaceuticals's EV-to-Revenue for today is:

Poniard Pharmaceuticals's current Enterprise Value is $0.00 Mil.
Poniard Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Sep. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Enterprise Value Related Terms

Thank you for viewing the detailed overview of Poniard Pharmaceuticals's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Poniard Pharmaceuticals (Poniard Pharmaceuticals) Business Description